Corcept Therapeutics | CORT - Ebitda

Stock Price
46.06
Daily Change
0.98 2.17%
Monthly
13.81%
Yearly
-35.77%
Q2 Forecast
45.07

Corcept Therapeutics reported $4.2M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
ANI Pharmaceuticals USD 65.36M 5.76M Dec/2025
Ardelyx USD 6.02M 447K Dec/2025
Aurora Cannabis CAD 18.48M 3.11M Dec/2025
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Bristol-Myers Squibb USD 4.24B 967M Sep/2025
Canopy Growth CAD -2.87M 19.49M Dec/2025
Corcept Therapeutics USD 4.2M 6.5M Dec/2025
Eli Lilly USD 7.88B 378.1M Sep/2025
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
J&J USD 7.19B 2.32B Dec/2025
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Lexicon Pharmaceuticals USD -12.04M 15.95M Sep/2025
Merck USD 8.39B 1.97B Sep/2025
Nektar Therapeutics USD -31.81M 70K Sep/2023
Novartis USD 4.77B 1.11B Dec/2025
Novartis USD 5.84B 235M Sep/2025
Omeros USD -47.96M 7.39M Sep/2023
Pacira USD 38.71M 10.65M Dec/2025
Pfizer USD 6.08B 351M Sep/2025
Supernus Pharmaceuticals USD 48.5M 6.6M Dec/2025
TG Therapeutics USD 32.69M 5M Sep/2025